NCT06388135 2024-04-29Serplulimab Combined With Nab-paclitaxel and Cisplatin in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell CarcinomaXijing HospitalPhase 4 Not yet recruiting80 enrolled